default author photo

Kristina A. Tendl-Schulz

Medical University of Vienna

Vienna

Austria

SCHOLARLY PAPERS

1

DOWNLOADS

40

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Her2/Cep17 Ratio Predicts Residual Cancer Burden after Neoadjuvant Dual Her2 Blockade: Real-World Data of Women with Primary Her2-Amplified Breast Cancer

Number of pages: 29 Posted: 04 Dec 2024
Medical University of Vienna, Medical University of Vienna, Medical University of Vienna - Department of Obstetrics and Gynecology, Medical University of Vienna, Medical University of Vienna, affiliation not provided to SSRN, affiliation not provided to SSRN, Medizinische Universität Wien, Medical University of Vienna, Medical University of Vienna, Medical University of Vienna, Medical University of Vienna, Medical University of Vienna and Medical University of Vienna
Downloads 40 (1,183,237)

Abstract:

Loading...

HER2/CEP17 ratio, early-stage breast cancer, neoadjuvant dual HER2 blockade, residual cancer burden, HER2 positivity